Buckingham Strategic Partners 10x Genomics, Inc. Transaction History
Buckingham Strategic Partners
- $8.25 Billion
- Q3 2025
A detailed history of Buckingham Strategic Partners transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Buckingham Strategic Partners holds 21,979 shares of TXG stock, worth $349,246. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,979
Previous 25,103
12.44%
Holding current value
$349,246
Previous $290,000
11.72%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TXG
# of Institutions
353Shares Held
118MCall Options Held
266KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA13.3MShares$211 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$189 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$102 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.44MShares$86.4 Million0.03% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.38MShares$85.5 Million0.04% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.51B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...